Literature DB >> 22733483

Lymphocytes in obesity-related adipose tissue inflammation.

A Chatzigeorgiou1,2, K P Karalis3,4,5, S R Bornstein3, T Chavakis6,7.   

Abstract

Inflammation in the white adipose tissue (WAT) is considered a major player in the development of insulin resistance. The role of macrophages accumulating in the WAT during obesity, promoting WAT inflammation and insulin resistance is well established. In contrast, less is known about the role of lymphocytes. Recent studies have implicated different lymphocyte subsets in WAT inflammation. For instance, cytotoxic CD8(+) T cells infiltrating the WAT may contribute to the recruitment, differentiation and activation of macrophages. On the other hand, a differential role for CD4(+) Th1 and CD4(+) Th2 cells has been suggested. Levels of WAT regulatory T cells decrease during the course of obesity and may represent a crucial factor for the maintenance of insulin sensitivity. Moreover, activation of natural killer T cells, an innate-like T cell population, which recognises lipid antigens, promotes insulin resistance and WAT inflammation. Finally, B cells may infiltrate WAT very early in response to high-fat feeding and worsen glucose metabolism through modulation of T cells and the production of pathogenic antibodies. These interesting new findings however bear controversies and introduce novel, yet unanswered, questions. Here, we review and discuss the impact of the different lymphocyte subsets in obesity-related WAT inflammation and attempt to identify the open questions to be answered by future studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733483     DOI: 10.1007/s00125-012-2607-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  88 in total

Review 1.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.

Authors:  Yaron Ilan; Ruth Maron; Ann-Marcia Tukpah; Tatiani Uceli Maioli; Gopal Murugaiyan; Kaiyong Yang; Henry Yim Wu; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

Review 3.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 4.  Adipose tissue recruitment of leukocytes.

Authors:  Emily K Anderson; Dario A Gutierrez; Alyssa H Hasty
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

5.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

6.  Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients.

Authors:  L Alberti; L Gilardini; A Girola; M Moro; F Cavagnini; C Invitti
Journal:  Diabetes Obes Metab       Date:  2007-05       Impact factor: 6.577

7.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.

Authors:  David Patsouris; Ping-Ping Li; Divya Thapar; Justin Chapman; Jerrold M Olefsky; Jaap G Neels
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

8.  Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice.

Authors:  Kazue Ohmura; Naoki Ishimori; Yoshinori Ohmura; Satoshi Tokuhara; Atsushi Nozawa; Shunpei Horii; Yasuhiro Andoh; Satoshi Fujii; Kazuya Iwabuchi; Kazunori Onoé; Hiroyuki Tsutsui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

Review 9.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

10.  Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.

Authors:  Jeffrey Deiuliis; Zubair Shah; Nilay Shah; Bradley Needleman; Dean Mikami; Vimal Narula; Kyle Perry; Jeffrey Hazey; Thomas Kampfrath; Madhukar Kollengode; Qinghua Sun; Abhay R Satoskar; Carey Lumeng; Susan Moffatt-Bruce; Sanjay Rajagopalan
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

View more
  48 in total

1.  γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice.

Authors:  Pooja Mehta; Alli Martina Nuotio-Antar; C Wayne Smith
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.

Authors:  Daniel B Harmon; Prasad Srikakulapu; Jennifer L Kaplan; Stephanie N Oldham; Chantel McSkimming; James C Garmey; Heather M Perry; Jennifer L Kirby; Thomas A Prohaska; Ayelet Gonen; Peter Hallowell; Bruce Schirmer; Sotirios Tsimikas; Angela M Taylor; Joseph L Witztum; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-11       Impact factor: 8.311

3.  CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance.

Authors:  Jeffrey A Deiuliis; Steve Oghumu; Dheeraj Duggineni; Jixin Zhong; Jessica Rutsky; Ambar Banerjee; Bradley Needleman; Dean Mikami; Vimal Narula; Jeffrey Hazey; Abhay R Satoskar; Sanjay Rajagopalan
Journal:  Obesity (Silver Spring)       Date:  2014-03-27       Impact factor: 5.002

4.  Resveratrol Delivery from Porous Poly(lactide- co-glycolide) Scaffolds Promotes an Anti-Inflammatory Environment within Visceral Adipose Tissue.

Authors:  Kendall P Murphy; Michael A Hendley; Christopher Isely; Prakasam Annamalai; Edsel Peña; R Michael Gower
Journal:  ACS Appl Mater Interfaces       Date:  2018-12-07       Impact factor: 9.229

5.  Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.

Authors:  Nathalie Esser; Laurent L'homme; Arnaud De Roover; Laurent Kohnen; André J Scheen; Michel Moutschen; Jacques Piette; Sylvie Legrand-Poels; Nicolas Paquot
Journal:  Diabetologia       Date:  2013-09-07       Impact factor: 10.122

Review 6.  Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.

Authors:  Vivekanandhan Aravindhan; Gowrishankar Anand
Journal:  Am J Trop Med Hyg       Date:  2017-10-26       Impact factor: 2.345

Review 7.  The role of innate immunity in the regulation of brown and beige adipogenesis.

Authors:  Vasileia Ismini Alexaki; Triantafyllos Chavakis
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

8.  The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.

Authors:  Julia Phieler; Kyoung-Jin Chung; Antonios Chatzigeorgiou; Anne Klotzsche-von Ameln; Ruben Garcia-Martin; David Sprott; Maria Moisidou; Theodora Tzanavari; Barbara Ludwig; Elena Baraban; Monika Ehrhart-Bornstein; Stefan R Bornstein; Hassan Mziaut; Michele Solimena; Katia P Karalis; Matina Economopoulou; John D Lambris; Triantafyllos Chavakis
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity.

Authors:  Xiaofeng Ding; Yan Luo; Xing Zhang; Handong Zheng; Xin Yang; Xuexian Yang; Meilian Liu
Journal:  J Endocrinol       Date:  2016-10       Impact factor: 4.286

Review 10.  The role of the complement system in metabolic organs and metabolic diseases.

Authors:  Julia Phieler; Ruben Garcia-Martin; John D Lambris; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2013-05-17       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.